Archives: Speakers

Stephen Bonsu is an accomplished leader with over 20 years of experience in biopharmaceutical development and business strategy.  He has extensive expertise in healthcare, clinical development, and commercialization across pharmaceutical and biotech portfolios. His career spans leadership roles focused on strategic portfolio management, regulatory affairs, and global supply chain coordination, with a strong emphasis on cross-functional team leadership and talent development.

• Leadership in Biopharma Development: Stephen Bonsu is a visionary and transformational leader with experience managing matrix teams across CMC, clinical operations, and regulatory affairs to drive organizational goals and portfolio execution.
• Expertise in Drug Development and Regulatory Strategy: Stephen has contributed to drug research, clinical development, and regulatory sciences, supporting global clinical trials and product delivery strategies, including risk mitigation and supply chain adaptation.
• Senior Roles at Eli Lilly & Company: Since January 2024, Stephen serves as Senior Director, overseeing commercial product regulatory and supply strategy for cardiometabolic and neuroscience portfolios, partnering with multiple functions to ensure clinical and commercial supply alignment.
• Leadership at Bristol-Myers Squibb: From 2018 onward, Stephen led clinical supply programs and global supply chain strategies for over a dozen portfolio assets across major therapeutic areas, managing risks for high-revenue brands and fostering cross-functional collaboration.
• Program and Talent Development: Stephen has led leadership development initiatives within the BMS BOLD ERG organization, focusing on minority talent growth and diversity, equity, and inclusion goals.
• Experience in Biologics and Biosimilars: Stephen headed CMC integration and program management at Adello Biologics, driving biosimilar clinical development and regulatory submissions with significant budget oversight.
• Entrepreneurial Venture: Stephen Founded and operated Teylev Café, managing business planning, operations, supply chain, and team leadership while maintaining a biopharma career.
• Educational Background and Skills: Stephen holds a Master of Business & Science with concentrations in drug discovery and development, and a Bachelor of Science in Physics. Certified in project management and Six Sigma, with proficiency in program leadership, clinical and commercial drug development, and budget management.

David Kurtz is Director of Research & Analysis for Construction, Mining and Energy at GlobalData, and is responsible for all of the company’s published data and insights on these sectors. He joined the company from Datamonitor in 2013, where he spent 10 years based in London leading the Energy and Utilities business unit, before moving to Sydney in 2004 to head up the Asia Pacific operations, managing all research, analysis and sales and in the region.

Roger Young is a Senior Field Technical Advisor at Imperial Oil for the past 13 years. With his background as a technician and as a certified lubrication expert, Roger’s focus is to provide solutions to the mining operation around productivity, environmental care, and safety.

Päivi is Project Manager in the Clinical Trials Unit at the Danish Medicines Agency, where she has been involved in the approval of clinical trials for the past four years. Prior to this role, she held various regulatory positions within competent authorities and the pharmaceutical industry.